UNSPSC 51283207: Sedecamycin

This classification denotes a macrolide antibiotic with the molecular formula C27H35NO8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WLK252Z51F, chemically known as pyruvamide, n-(7,13-dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo(13.2.2)nonadeca-3,5,9,11-tetraen-2-yl)-, 13-acetate, (all-e)-(1s,2r,7s,13s,15r,19r)-(-)- but generally known as sedecamycin, which bears US NIH Compound Identifier 5382567.

UNSPSC 51283207 Sedecamycin, a Commodity code, nominally denotes a specific antibiotic class but recent state and local procurement activity shows limited direct buying under this code designation. The two recent opportunities recorded use this code tag despite procuring different pharmaceutical products — one for broad-spectrum antibiotics (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) through a state cooperative purchasing vehicle, and another for emergency-response pharmaceuticals (Naloxone) and drug deactivation systems. State and local health departments and county public-health agencies drive the visible demand, with orders typically structured as fixed-term supply contracts through piggyback or competitive bid processes, often with renewal options and quarterly or on-call delivery schedules.

Illinois Department of Public Health and Seminole County, Florida appear in the recent record. The Illinois procurement, awarded August 28, 2026, was a piggyback award through the MMCAP Infuse consortium to Chartwell Rx LLC for $2.999 million over 12 months plus two renewal years, supplying Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under an Invitation for Bid process. Seminole County's IFB 60459723LAS, posted June 30, 2026, sought annual supplies of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly delivery to Sanford, Florida, on a two-year initial term with one-year renewal option; the bid deadline was July 26, 2023 (a data inconsistency in the source). Both procurements required E-Verify compliance and drug-free workplace certification, with no explicit set-aside designations recorded. Geographic activity centers on the Southeast and Midwest, though the code's sparse recent record suggests limited cross-jurisdictional standardization on this specific UNSPSC designation for pharmaceutical procurement.